Literature DB >> 15656834

Pioglitazone: a promising therapy for psoriasis.

H Robertshaw, P S Friedmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15656834     DOI： 10.1111/j.1365-2133.2005.06369.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  12 in total

1.  Peroxisome proliferator-activated receptors (PPARs) in dermatology: Challenge and promise.

Authors:  Pit Sertznig; Jörg Reichrath
Journal:  Dermatoendocrinol       Date:  2011-07-01

Review 2.  Lipid disturbances in psoriasis: an update.

Authors:  Aldona Pietrzak; Anna Michalak-Stoma; Grazyna Chodorowska; Jacek C Szepietowski
Journal:  Mediators Inflamm       Date:  2010-07-20       Impact factor: 4.711

3.  Peroxisome proliferator-activated receptor γ B cell-specific-deficient mice have an impaired antibody response.

Authors:  Sesquile Ramon; Simona Bancos; Thomas H Thatcher; Thomas I Murant; Safiehkhatoon Moshkani; Julie M Sahler; Andrea Bottaro; Patricia J Sime; Richard P Phipps
Journal:  J Immunol       Date:  2012-10-05       Impact factor: 5.422

Review 4.  Nuclear receptor function in skin health and disease: therapeutic opportunities in the orphan and adopted receptor classes.

Authors:  Kelvin Yin; Aaron G Smith
Journal:  Cell Mol Life Sci       Date:  2016-08-20       Impact factor: 9.261

5.  Role of peroxisome proliferator-activated receptor gamma and its ligands in the treatment of hematological malignancies.

Authors:  Tatiana M Garcia-Bates; Geniece M Lehmann; Patricia J Simpson-Haidaris; Steven H Bernstein; Patricia J Sime; Richard P Phipps
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

6.  Randomized placebo control study of insulin sensitizers (Metformin and Pioglitazone) in psoriasis patients with metabolic syndrome (Topical Treatment Cohort).

Authors:  Surjit Singh; Anil Bhansali
Journal:  BMC Dermatol       Date:  2016-08-17

7.  Accelerated Barrier Repair in Human Skin Explants Induced with a Plant-Derived PPAR-α Activating Complex via Cooperative Interactions.

Authors:  George Majewski; John Craw; Timothy Falla
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-09-18

8.  No association of multiple type 2 diabetes loci with type 1 diabetes.

Authors:  S M Raj; J M M Howson; N M Walker; J D Cooper; D J Smyth; S F Field; H E Stevens; J A Todd
Journal:  Diabetologia       Date:  2009-05-20       Impact factor: 10.122

9.  Peroxisome proliferator-activated receptor agonists (PPARs): a promising prospect in the treatment of psoriasis and psoriatic arthritis.

Authors:  Emerson de Andrade Lima; Mariana Modesto Dantas de Andrade Lima; Cláudia Diniz Lopes Marques; Angela Luzia Branco Pinto Duarte; Ivan da Rocha Pita; Maira Galdino da Rocha Pita
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

10.  Keratinocyte-derived IL-1β induces PPARG downregulation and PPARD upregulation in human reconstructed epidermis following barrier impairment.

Authors:  Stefan Blunder; Thomas Krimbacher; Verena Moosbrugger-Martinz; Robert Gruber; Matthias Schmuth; Sandrine Dubrac
Journal:  Exp Dermatol       Date:  2021-03-18       Impact factor: 3.960
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.